Irinotecan ic50
Webirinotecan Cell line Irinotecan IC50 (μM) SW620 1.53 LS180 3.11 COLO741 3.57 COLO205 7.23 LOVO 7.64 CX-1 8.69 GP2D 9.89 SW48 10.02 RKO 10.78 HCT116 14.84 HCT15 17.81 SW480 18.26 SW1116 27.22 DLD1 28.58 CACO-2 30.90 D2 36.60 SW837 46.42 GP5D 47.22 CO115 53.95 HT29 120 LS174T 150 Figure 1. Determination of IC50 doses for 21 CRC cell WebIrinotecan (CPT-11, (+)-Irinotecan) is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively. Camptothecin (NSC-100880, CPT, …
Irinotecan ic50
Did you know?
WebMay 22, 2024 · Background We investigated the role of the ETS-1 transcription factor in Head and Neck Squamous Cell Carcinoma (HNSCC) in multiple cisplatin-resistant HNSCC cell lines. Methods We examined its molecular link with SRC and MEK/ERK pathways and determined the efficacy of either MEK/ERK inhibitor PD0325901 or SRC inhibitor Dasatinib … WebDec 12, 2024 · IC50 for susceptible cells was 0.03 μg/mL, while it was 5.7 μg/mL for resistant cells (Fanciulli et al., 2000). ... Approximately 47-fold resistance to irinotecan developed in S1 colon-cancer cells upon pulsed exposure to the agent (0.5 μM) for 48 h with a 7-day interruption (Wu et al., 2024). After three to five cycles of drug treatment ...
WebApr 15, 2014 · Determination of IC50 doses for 21 CRC cell lines. 21 CRC cell lines were treated with nine doses of irinotecan for 144 h, and then the cell viability was detected by … WebNational Center for Biotechnology Information
Web特别声明:本产品及我公司所售其他产品均为科研类试剂产品,严禁用于药物、医疗及其他非科研用途。 DNA解旋抑制剂(Irinotecan)厂家现货的品牌:百奥莱博,是优质的抑制剂激活剂产品,用于科研实验,本产品质量好,且极具价格优势,深为用户称道,了解更多DNA解旋抑 … WebIrinotecan (CPT-11, (+)-Irinotecan) is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively. CAS No. 97682-44-5 Selleck's …
WebUS20240074866A1 US17/703,312 US202417703312A US2024074866A1 US 20240074866 A1 US20240074866 A1 US 20240074866A1 US 202417703312 A US202417703312 A US 202417703312A US 2024074866 A
WebMar 1, 2001 · Results: Irinotecan was investigated as second-line chemotherapy after prior treatment with fluorouracil (FU)-based regimens in two large randomized phase III trials comparing irinotecan with either best supportive care or … high schools in decatur gaWebJan 22, 2016 · Irinotecan, etirinotecan and topotecan have also been tested in clinical trials in mBC , and irinotecan and etirinotecan regimens were shown to benefit a considerable … high schools in derby ctWebThe SDF1/CXCR4 signaling has Irinotecan ic50 been recognized as a critical pathway for the homing and tissue retention of hematopoietic progenitor/stem Irinotecan ic50 cells in the … high schools in dc areaWebA- IC50 values after in vitro exposure for 30 min of CRC cells SW480, HT28, HCT116 and HCT8 with Oxaliplatin, 5 FU, Cisplatin, GEM, Irinotecan and Raltitrexed. B- Dose-response curves after... high schools in daytona beach flWebJul 23, 2014 · Irinotecan is a potent inhibitor of DNA topoisomerase 1 ( 5) and has been reported to be active in recurrent SCLC patients in several Phase II trials. Patients were treated with irinotecan at a dosage of 100–125 mg/m 2 weekly or 350 mg/m 2 on Day 1 every 3 weeks in these studies ( 6–9 ). high schools in dayton ohWebIrinotecan (CPT-11, (+)-Irinotecan) hydrochloride is an inhibitor of Topoisomerase I (Topo I) that exhibits cytotoxicity in LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively. CAS No. 100286-90-6 Selleck's Irinotecan hydrochloride has been cited by 14 publications Adv Sci (Weinh),2024e2201539 Cancers (Basel),202414 (5)1230 high schools in deltona flWebJan 22, 2016 · Currently used Top1 targeting drugs, such as irinotecan, etirinotecan (NKTR-102), or topotecan are derivatives of camptothecin. However, non-camptothecin derived next generation Top1 inhibitors, such as indenoisoquinolines, are currently being tested in clinical trials [ 4, 5] with promising results ( http://clinicaltrials.gov/show/NCT01245192 ). high schools in derby